Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
CN Stock MarketDetailed Quotes
688198 Beijing Balance Medical Technology Co., Ltd.
- 118.38
- +2.75+2.38%
Market Closed Apr 24 15:00 CST
16.26BMarket Cap95.39P/E (TTM)
118.49High115.10Low3.80KlotVolume116.58Open115.63Pre Close44.42MTurnover0.28%Turnover Ratio111.15P/E (Static)137.40MShares166.0052wk High12.64P/B16.26BFloat Cap92.5552wk Low138.76Limit Up137.40MShs Float234.06Historical High92.50Limit Down2.93%Amplitude20.20Historical Low0.80Dividend TTM116.79Avg Price1.46KlotAsk0.68%Div YieldTTM100Lot Size1.99KlotBid
Beijing Balance Medical Technology Co., Ltd. Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 31.30%100.14M | 35.41%501.88M | 13.57%292.32M | 13.74%190.68M | 17.53%76.27M | 25.57%370.64M | 16.60%257.39M | 18.95%167.64M | -1.69%64.89M | 17.21%295.17M |
| Operating revenue | 31.30%100.14M | 35.41%501.88M | 13.57%292.32M | 13.74%190.68M | 17.53%76.27M | 25.57%370.64M | 16.60%257.39M | 18.95%167.64M | -1.69%64.89M | 17.21%295.17M |
| Total operating cost | 4.79%80.04M | 33.94%362.25M | 24.33%245.18M | 24.43%163.45M | 35.52%76.38M | 28.17%270.46M | 21.37%197.2M | 26.36%131.36M | 7.12%56.36M | -3.87%211.01M |
| Operating cost | 74.99%14.3M | 55.49%58.52M | 25.83%33.43M | 10.84%20.46M | 8.45%8.17M | 20.02%37.64M | 17.22%26.57M | 22.94%18.46M | 0.66%7.54M | 5.92%31.36M |
| Operating tax surcharges | 153.22%1.34M | 99.10%4.2M | 49.26%2.38M | 68.28%1.76M | 22.59%530.8K | 23.81%2.11M | 22.60%1.6M | 17.29%1.05M | -4.89%432.98K | 38.66%1.7M |
| Operating expense | -0.80%23.41M | 21.07%121.96M | -1.90%81.74M | -5.97%53.61M | -3.49%23.6M | 0.69%100.73M | 8.57%83.32M | 13.51%57.01M | 0.15%24.45M | -9.38%100.04M |
| Administration expense | 2.48%8.4M | 5.52%32.96M | -2.62%22.41M | -6.12%14.9M | 22.22%8.2M | 31.65%31.24M | 29.30%23.01M | 51.99%15.87M | 13.26%6.71M | 14.32%23.73M |
| Financial expense | 87.32%-536.24K | -9,616.95%-6.84M | -898.93%-3.76M | -991.24%-4.34M | -2,342.78%-4.23M | 92.76%-70.35K | 39.81%-376.85K | 27.84%-398.07K | 51.94%-173.17K | 29.93%-971.79K |
| -Interest expense (Financial expense) | -12.01%106.56K | 11.55%462.63K | 48.84%358.59K | 89.42%241.84K | 653.31%121.11K | 419.14%414.74K | 285.84%240.92K | 205.15%127.67K | -23.08%16.08K | -32.64%79.89K |
| -Interest Income (Financial expense) | 83.37%-731.93K | -829.21%-7.31M | -669.74%-4.79M | -922.66%-4.68M | -2,016.35%-4.4M | 29.16%-786.66K | 15.23%-622.22K | 25.56%-457.78K | 47.70%-208K | 28.87%-1.11M |
| Research and development | -17.44%33.12M | 53.26%151.44M | 72.77%108.99M | 95.78%77.07M | 130.45%40.11M | 79.18%98.81M | 41.45%63.08M | 40.96%39.36M | 18.43%17.4M | -6.37%55.15M |
| Credit Impairment Loss | 74.63%67.14K | -67.51%-2.49M | -4.36%-612.53K | -250.36%-283.06K | -91.01%38.45K | 13.58%-1.49M | 39.60%-586.92K | 120.02%188.25K | 484.32%427.74K | -113.74%-1.72M |
| Other net revenue | ||||||||||
| Fair value change income | 18.84%497.47K | -25.72%742.3K | -80.21%643.98K | -84.15%313.89K | -65.07%418.59K | 12.43%999.39K | 16.91%3.25M | -3.96%1.98M | -25.41%1.2M | -8.17%888.92K |
| Invest income | -29.33%1.98M | -40.67%10.01M | -2.60%7.63M | -1.74%5.55M | 3.58%2.8M | -21.20%16.87M | 20.00%7.84M | 24.80%5.65M | 79.61%2.71M | 43.43%21.41M |
| Asset deal income | ---- | -99.36%362.99 | -99.70%149.61 | ---- | ---- | 344.97%56.58K | 291.55%49.79K | 291.55%49.79K | ---- | 42.43%12.72K |
| Other revenue | 581.07%14.49M | 27.03%5.33M | 13.81%4.37M | -33.57%2.39M | 72.04%2.13M | 57.33%4.19M | 70.30%3.84M | 1,432.82%3.59M | 440.47%1.24M | -48.69%2.67M |
| Operating profit | 603.97%37.14M | 26.82%153.22M | -20.66%59.17M | -26.28%35.2M | -62.59%5.28M | 12.47%120.82M | 8.29%74.58M | 11.36%47.75M | -15.24%14.1M | 104.18%107.42M |
| Add:Non operating Income | -4.18%34.63K | -84.67%47.05K | 39.60%46.44K | 33.28%44.33K | 15.40%36.14K | 1,604.12%306.99K | 85.22%33.26K | 89.00%33.26K | 77.95%31.32K | -83.09%18.01K |
| Less:Non operating expense | 399.66%2.5M | 123.77%2.48M | 257.44%2.17M | 4.10%631.07K | 75,316.50%500.34K | -14.80%1.11M | 16.91%607.29K | 44.56%606.21K | -99.83%663.43 | -56.03%1.3M |
| Total profit | 620.65%34.68M | 25.64%150.79M | -22.92%57.05M | -26.63%34.61M | -65.95%4.81M | 13.08%120.02M | 8.24%74M | 11.07%47.18M | -13.10%14.13M | 113.31%106.14M |
| Less:Income tax cost | 390.83%4.49M | 75.73%18.64M | 27.12%7.04M | 85.21%6.56M | -66.19%915.4K | -9.65%10.61M | -38.04%5.54M | -34.31%3.54M | 0.52%2.71M | 879.63%11.74M |
| Net profit | 674.65%30.18M | 20.78%132.14M | -26.96%50.01M | -35.71%28.05M | -65.90%3.9M | 15.91%109.41M | 15.20%68.47M | 17.67%43.63M | -15.81%11.43M | 84.14%94.39M |
| Net profit from continuing operation | 674.65%30.18M | 20.78%132.14M | -26.96%50.01M | -35.71%28.05M | -65.90%3.9M | 15.91%109.41M | 15.20%68.47M | 17.67%43.63M | -15.81%11.43M | 84.14%94.39M |
| Less:Minority Profit | 47.51%-2.32M | -144.69%-14.19M | -362.07%-8.69M | -1,116.42%-7.14M | -1,521.90%-4.42M | -691.19%-5.8M | -345.08%-1.88M | -170.61%-587.05K | -651.24%-272.74K | -1,228.88%-732.79K |
| Net profit of parent company owners | 290.69%32.5M | 27.02%146.33M | -16.56%58.69M | -20.42%35.19M | -28.88%8.32M | 21.11%115.21M | 17.53%70.35M | 18.56%44.22M | -14.03%11.7M | 85.80%95.13M |
| Earning per share | ||||||||||
| Basic earning per share | 300.00%0.24 | 25.88%1.07 | -17.31%0.43 | -21.21%0.26 | -33.33%0.06 | 21.43%0.85 | 18.18%0.52 | 17.86%0.33 | -10.00%0.09 | 84.21%0.7 |
| Diluted earning per share | 300.00%0.24 | 27.38%1.07 | -15.69%0.43 | -18.75%0.26 | -33.33%0.06 | 20.00%0.84 | 15.91%0.51 | 18.52%0.32 | -10.00%0.09 | 84.21%0.7 |
| Other composite income | -102.37%-32.95K | -75.07%320.54K | -116.37%-296.62K | -88.09%262.58K | 3,821.35%1.39M | 10,062.72%1.29M | 1,932.08%1.81M | 1,324.59%2.21M | -79.59%35.49K | -78.87%12.65K |
| Other composite income of parent company owners | -102.37%-32.95K | -75.07%320.54K | -116.37%-296.62K | -88.09%262.58K | 3,821.35%1.39M | 10,062.72%1.29M | 1,932.08%1.81M | 1,324.59%2.21M | -79.59%35.49K | -78.87%12.65K |
| Total composite income | 470.14%30.15M | 19.67%132.46M | -29.27%49.71M | -38.23%28.31M | -53.86%5.29M | 17.25%110.69M | 18.07%70.28M | 23.10%45.84M | -16.61%11.46M | 83.95%94.41M |
| Total composite income of parent company owners | 234.36%32.47M | 25.89%146.65M | -19.07%58.4M | -23.63%35.45M | -17.23%9.71M | 22.44%116.49M | 20.38%72.16M | 23.96%46.43M | -14.85%11.73M | 85.61%95.14M |
| Total composite income of minority owners | 47.51%-2.32M | -144.69%-14.19M | -362.07%-8.69M | -1,116.42%-7.14M | -1,521.90%-4.42M | -691.19%-5.8M | -345.08%-1.88M | -170.61%-587.05K | -651.24%-272.74K | -1,228.88%-732.79K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | -- | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs